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permeability to protein during acute, bacterial peritonitis inEffect of indomethacin on peritoneal protein loss in a rabbit
the rabbit.model of peritonitis.
Background. Although various inflammatory mediators have
been previously shown to be released into the peritoneal cavity
during peritonitis in peritoneal dialysis patients, those that are Peritonitis causes significant morbidity in chronic peri-involved in governing changes in peritoneal permeability to
toneal dialysis patients [1, 2]. During the acute phase ofsmall solutes and protein remain incompletely defined.
peritonitis, there is rapid migration of leukocytes into theMethods. We determined the importance of prostanoid pro-
duction in the enhanced protein loss observed during acute peritoneal cavity and an increase in the permeability of
peritonitis by inhibition experiments using indomethacin, an the peritoneum or peritoneal membrane to both protein
inhibitor of cyclooxygenase activity. The association between [3] and small solutes. The latter change in peritoneal per-changes in peritoneal permeability and the generation of in-
meability also results in a loss of ultrafiltration capacityflammatory mediators after adding Escherichia coli to perito-
and decreased clearances of urea and creatinine [4, 5]. Theneal dialysate was first examined in series 1 experiments. Series
2 experiments then determined the effect of intraperitoneal mechanisms governing changes in peritoneal permeability
administration of indomethacin (75 mg/mL) on changes in peri- during peritoneal inflammation remain incompletely de-
toneal permeability after adding E. coli to peritoneal dialysate. fined.
All experiments were performed in male New Zealand White
Local production of inflammatory mediators within therabbits (2.6 to 3.4 kg body weight) using an eight-hour dwell
peritoneum [6], some of which can direct leukocyte migra-of dialysate containing 2.5% glucose. Peritoneal permeability
to creatinine and protein was assessed by time-dependent tion into the peritoneal cavity [7], has been associated with
changes in the dialysate to plasma concentration ratios of these changes in peritoneal permeability during peritonitis. For
solutes. example, Steinhauer and Schollmeyer showed that peri-
Results. Series 1 experiments showed enhanced leukocyte toneal dialysate concentrations of prostaglandin E2 (PGE2),migration into the peritoneal cavity and increased peritoneal
6-keto-PGF1a, PGF2a and thromboxane B2 increased dur-permeability to protein during bacterial challenge that was
ing episodes of peritonitis in continuous ambulatory peri-accompanied by an increase in the dialysate concentrations of
prostaglandin E2 (PGE2), 6-keto-PGF1a, and interleukin-8, but toneal dialysis (CAPD) patients and that dialysate con-
not nitrate 1 nitrite (a measure of local nitric oxide produc- centrations of PGE2 and 6-keto-PGF1a correlated with
tion). Inhibition of prostanoid production by intraperitoneal the increased loss of proteins into the dialysate [8]. The
administration of indomethacin in series 2 experiments resulted
importance of inflammatory mediators in regulatingin lower dialysate concentrations of PGE2 and 6-keto-PGF1a
changes in peritoneal permeability during peritonitis inand in lower peritoneal permeability to protein, both to control
levels. No effect of indomethacin on transperitoneal migration CAPD patients was further supported by Zemel et al,
of leukocytes or the generation of interleukin-8 was observed. who showed that increased transperitoneal transport of
Conclusions. Enhanced production of prostanoids likely protein and small solutes correlated with enhanced ap-
plays an important role in governing the increase in peritoneal
pearance rates of tumor necrosis factor-a (TNF-a), in-
terleukin-6 (IL-6), and prostaglandins in peritoneal dial-
ysate [9]. In that study, increases in transperitonealKey words: prostanoid, bacterial peritonitis, inflammatory mediators,
cyclooxygenase, interleukins, nitric oxide. transport of small solutes correlated best with dialysate
IL-6 concentrations, and changes in peritoneal perme-
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the peritoneal cavity and enhanced protein loss rates has respectively. The peritoneal cavity was then penetrated,
and a peritoneal catheter (Sil-Med Corporation, Tauton,also been demonstrated in the rabbit during zymosan-
induced peritonitis [10]. Other more recent studies have MA, USA) was inserted and secured with a purse-string
suture. No additional anesthesia was given after surgeryproposed that local production of nitric oxide can medi-
ate changes in transperitoneal transport of both protein was completed.
After surgical preparation, a baseline arterial bloodand small solutes during peritonitis in the rat [11–13].
Despite these previously reported statistical correlations, sample was obtained. A washout exchange of the perito-
neal cavity was then performed using 100 mL of Normo-the relative importance of prostanglandins, cytokines,
and nitric oxide in altering peritoneal permeability dur- sol Rt (Abbott Laboratories, North Chicago, IL, USA)
for 15 minutes. Normosol Rt solutions had a pH of 6.8ing peritonitis remains unclear.
We have developed a rabbit model of acute peritonitis and contained 140 mEq/L sodium, 5 mEq/L potassium,
98 mEq/L chloride, 27 mEq/L acetate, 3 mEq/L magne-that elicits both enhanced leukocyte migration into the
peritoneal cavity and increased peritoneal permeability sium, and 23 mEq/L gluconate. A priming dose of 100
mg of creatinine (Sigma Chemical, St. Louis, MO, USA)to protein during the first eight hours of infection (ab-
stract; Liu et al, J Am Soc Nephrol 5:462, 1994). In the dissolved in 20 mL of Normosol Rt was infused intrave-
nously during a 10-minute interval. This was followed bypresent study, we describe the local release of certain
inflammatory mediators into the peritoneal cavity in this a constant infusion of a Normosol Rt solution containing
1.65 mg/mL creatinine at a rate of 1.15 mL/min to main-model and determine the importance of prostanoid pro-
duction in controlling protein permeability during perito- tain a plasma creatinine concentration of approximately
10 mg/dL. After drainage of the washout exchange bynitis by inhibition experiments using indomethacin, an
inhibitor of cyclooxygenase (COX) activity. gravity, 120 mL of the dialysis solution (Dianeal PD-2)
were instilled into the peritoneal cavity containing E.
coli and indomethacin as required by the experimental
METHODS
design. All solutions were warmed to 378C before infu-
Experimental design sion into the rabbit.
Three milliliters of blood and 4 mL of dialysate wereTwo separate series of peritoneal dialysis experiments
were performed in male New Zealand White rabbits obtained at 0, 2, 4, 6, and 8 hours after complete infusion
of the dialysate into the peritoneal cavity. One hundredweighing between 2.6 and 3.4 kg. Series 1 experiments
compared transperitoneal solute transport rates and dial- microliters were taken from each of these dialysate sam-
ples to determine total and differential leukocyte counts,ysate concentrations of inflammatory mediators after the
addition of 1 3 106 colony forming units (cfu) of Esche- and the remainder was centrifuged to ensure complete
removal of particles and cells. The supernatant was col-richia coli (E. coli; catalog number 25922, N 5 7; Ameri-
can Type Culture Collection, Rockville, MD, USA) to the lected immediately into tubes containing sodium ethyl-
enediaminetetraacetic acid, pH 7.2, and indomethacinperitoneal cavity with those from control rabbits without
bacteria added to the dialysate (N 5 7). Series 2 experi- (10 mmol/L and 5.6 mmol/L final concentrations, respec-
tively) and was stored at 2708C until assays were per-ments compared transperitoneal solute transport rates
and dialysate concentrations of inflammatory mediators formed. Additional 1 mL dialysate samples were ob-
tained at 0.5, 1, and 3 hours after complete infusion of thewith (N 5 4) and without (N 5 4) intraperitoneal admin-
istration of indomethacin (Merck, West Point, PA, USA) dialysate for determination of small solute and protein
concentrations only. After taking the last samples, theat a concentration of 75 mg/mL to dialysate containing
5 3 105 cfu of E. coli. In all experiments, rabbits under- peritoneal cavity was drained by gravity for five minutes,
and the drained volume was measured to the nearestwent an eight-hour exchange using 120 mL of dialysate
containing 2.5% glucose (Dianeal PD-2; Baxter Health- milliliter using a graduated cylinder. The experiment was
then terminated by a barbiturate overdose.care, Deerfield, IL, USA).
Surgical procedure and experimental protocol Analytical techniques
Leukocytes in dialysate were counted using a hemocy-The surgical procedure and protocol for evaluating
peritoneal permeability in these experiments were simi- tometer. The percentage of neutrophils in the dialysate
was determined by using Wright’s stain (Sigma Chemi-lar to those previously published [14, 15]. Rabbits fasted
overnight and were anesthetized by an intramuscular cal). Plasma and dialysate concentrations of creatinine,
glucose, and protein were measured using an automatedinjection of acepromazine maleate (16 mg/kg) and xyla-
zine hydrochloride (3 mg/kg), followed 10 minutes later analyzer (Beckman CX3, Fullerton, CA, USA). Creati-
nine concentrations were corrected for high glucose con-by an intramuscular injection of ketamine hydrochloride
(50 mg/kg). A carotid artery and jugular vein were cannu- centrations as described previously [15].
Prostaglandin E2 and 6-keto-PGF1a concentrations inlated for blood sampling and the infusion of solutions,
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Fig. 1. Dialysate leukocyte counts as a function of dwell time during
series 1 experiments. Results are shown after addition of E. coli to the Fig. 2. Dialysate to plasma concentration (D/P) for total protein as a
peritoneal cavity (s, N 5 7) and in control rabbits (j, N 5 7). There function of dwell time during series 1 experiments. Results are shown
was a substantial increase in dialysate leukocytes after intraperitoneal after addition of E. coli to the peritoneal cavity (s) and in control
addition of E. coli and four to eight hours of dwell (**P , 0.01). Error rabbits (j). Error bars denote 6 SEM, and the single asterisk denotes
bars denote 6 SEM. a significant increase (*P , 0.05) in D/P values at the indicated sampling
times after intraperitoneal addition of E. coli compared with control
values.
the dialysate were determined by using commercially
available immunoassays according to the instructions of
Statisticsthe manufacturer (R&D Systems, Minneapolis, MN,
All results were expressed as mean 6 SEM. The sig-USA). The minimum detection limit for both prostan-
nificance of differences in the measured parameters asoids was 36.2 pg/mL. IL-8 was measured in peritoneal
a function of dwell time between groups was first as-dialysate by using an enzyme-linked immunosorbent
sessed by analysis of variance (ANOVA) with repeatedassay (Endogen, Cambridge, MA, USA) with a mini-
measures. If this test indicated significant differencesmum detection limit of 2 pg/mL. To assess local produc-
between groups, the significance of differences at eachtion of nitric oxide, the sum total of both nitrate and
sampling time was assessed using a Student t test fornitrite (hereafter referred to as nitrate 1 nitrite) concen-
unpaired data. P values less than 0.05 were consideredtrations was determined using a colorimetric assay (Cay-
significant.man Chemical, Ann Arbor, MI, USA) with a minimum
detection limit of 2.5 mmol/L. The latter assay required
two steps. The first is the conversion of all nitrate to
RESULTSnitrite using nitrate reductase, and the second is the evalu-
ation of nitrite concentration using the Griess reagents. The effect of adding E. coli to peritoneal dialysate on
the time dependence of dialysate leukocyte counts and
Calculations the D/P protein concentration ratios is shown in Figures
1 and 2, respectively. The addition of E. coli to thePeritoneal permeability to creatinine and total protein
was evaluated by calculating the dialysate to plasma peritoneal cavity resulted in a substantial increase in
dialysate leukocyte counts after four hours and a signifi-(D/P) concentration ratio at each sampling time. When
the concentration in plasma was not measured at a given cant increase in the D/P protein concentration ratio at
one, two, and eight hours of the dwell. The increase indialysate sampling time, the value was interpolated from
the bracketing concentrations. Creatinine and protein dialysate leukocyte counts was primarily due to neutro-
phils; the percentage of leukocytes in the dialysate thatclearances averaged over the eight-hour dwell were cal-
culated by multiplying D/P for creatinine and total pro- were neutrophils at eight hours after the addition of E.
coli to the peritoneal cavity was 92 6 3% (P , 0.01,tein, respectively, by the drained volume and dividing
by the dwell time. Peritoneal permeability to glucose different from the 51 6 10% in control rabbits). Drained
volume and creatinine clearance were marginally higherwas evaluated by calculating the ratio of the dialysate
concentration at each sampling time to the dialysate con- (P 5 0.078 and P 5 0.088, respectively) after intraperito-
neal addition of E. coli than in control rabbits, and pro-centration immediately after complete infusion of the
dialysis solution into the peritoneal cavity (D/D0). tein clearance was significantly higher after intraperito-
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Table 1. Calculated and measured parameters after an 8-hour dwell
in series 1 experiments
Intraperitoneal
Control administration
rabbits of E. coli
Drained dialysate volume mL 9069 117611
Creatinine clearance mL/min 0.1960.02 0.2460.02
Protein clearance lL/min 9.661.1 16.161.4b
Dialysate 6-keto-PGF1a concentration
ng/mL 10.961.4 14.562.2
Dialysate PGE2 concentration pg/mL 202620 426667b
Dialysate nitrate/nitrite concentration
lmol/L 3.661.0 5.761.4
Dialysate IL-8 concentration pg/mL 0.360.3 115.7643.5a
Mean 6 SEM values are shown.
a Higher than in control animals (P , 0.05)
b Higher than in control animals (P , 0.01)
neal addition of E. coli than in control rabbits (Table 1).
These data show that the addition of E. coli to the perito-
neal cavity resulted in enhanced leukocyte migration into
the peritoneal cavity and increased peritoneal perme-
ability to protein. These results are similar to those pre-
viously reported by ourselves (abstract; Liu et al, J Am
Soc Nephrol 5:462, 1994) and others [10] after intraperi-
toneal addition of an inflammatory stimulus in the rabbit.
The effect of intraperitoneal addition of E. coli on dialy-
sate concentrations of inflammatory mediators is shown
in Figure 3 and Table 1. Figure 3 shows the time depen-
dence of 6-keto-PGF1a (Fig. 3A) and PGE2 (Fig. 3B)
concentrations in the dialysate during series 1 experi-
Fig. 3. Dialysate 6-keto-PGF1a (A) and PGE2 (B) concentrations as aments. Intraperitoneal addition of E. coli resulted in an function of dwell time during series 1 experiments. Results are shown
after addition of E. coli to the peritoneal cavity (s) and in controlincrease in the dialysate concentration of 6-keto-PGF1a
rabbits (j). Error bars denote 6 SEM, and *P , 0.05 and **P ,after six hours and of PGE2 after eight hours. There was no 0.01 in dialysate concentrations after intraperitoneal addition of E. coli
increase in nitrate 1 nitrite concentrations in the dialysate compared with control values, respectively.
with dwell time in series 1 experiments, and intraperito-
neal addition of E. coli did not result in higher dialysate
nitrate 1 nitrite concentrations than those determined
findings show that intraperitoneal administration of in-in control rabbits (Table 1). Dialysate concentrations
domethacin resulted in peritoneal permeability to pro-of IL-8 were not consistently detectable in peritoneal
tein similar to that observed in control rabbits not ex-dialysate until eight hours of the dwell. Intraperitoneal
posed to bacteria in the dialysate (compare with theaddition of E. coli resulted in a substantial increase in
results from series 1 experiments).dialysate IL-8 concentrations after eight hours (Table 1).
As expected, intraperitoneal administration of indo-Figures 4 and 5 show the time dependence of dialysate
methacin blocked prostanoid production during acuteleukocyte counts and D/P protein concentration ratios
peritonitis, as reflected by 6-keto-PGF1a and PGE2 con-in series 2 experiments in which E. coli was added to
centrations in the dialysate (Fig. 6 and Table 2) thatthe dialysate for both groups of rabbits. There was no
were similar to those in control rabbits not exposed toeffect of intraperitoneal administration of indomethacin
bacteria in the dialysate. In contrast, dialysate concentra-on the increase in dialysate leukocyte counts with dwell
tions of nitrate 1 nitrite and IL-8 were not influencedtime (Fig. 4), and the percentage of leukocytes in the
by intraperitoneal administration of indomethacin.dialysate that were neutrophils was 95 6 1% with or
Figure 7 shows the time dependence of D/P concentra-without intraperitoneal administration of indomethacin.
tion ratios for creatinine during both series 1 and 2 exper-In contrast, intraperitoneal administration of indometha-
iments. There was no effect of any study intervention oncin resulted in lower D/P protein concentration ratios
either D/P creatinine or D/D0 glucose (data not shown).(Fig. 5), lower creatinine and protein clearances (Table 2),
and lower drained volumes of dialysate (Table 2). These These findings demonstrate that the addition of bacteria
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Fig. 5. Dialysate to plasma concentration (D/P) for total protein as aFig. 4. Dialysate leukocyte counts as a function of dwell time during function of dwell time during series 2 experiments. Results are shownseries 2 experiments. Results are shown after intraperitoneal addition after intraperitoneal addition of E. coli without intraperitoneal adminis-
of E. coli without intraperitoneal administration of indomethacin (j, tration of indomethacin (j, N 5 4) and after intraperitoneal addition
N 5 4) and after intraperitoneal addition of both E. coli and indometha- of both E. coli and indomethacin (s, N 5 4). Error bars denote 6
cin (s, N 5 4). There was no effect of intraperitoneal administration SEM, and *P , 0.05 and **P , 0.01 denote significant decreases
of indomethacin on dialysate leukocyte counts. Error bars denote 6 in D/P values at the indicated sampling times after intraperitoneal
SEM. administration of indomethacin compared with control values, respec-
tively.
to the peritoneal cavity of the rabbit does not substan-
Table 2. Calculated and measured parameters after an 8-hour dwelltially alter peritoneal permeability to small solutes in the in series 2 experiments
initial stage (the first 8 hours) of peritonitis and that
Intraperitonealany differences in creatinine clearance in this model are Intraperitoneal administration
largely due to differences in drained volume. administration of E. coli and
of E. coli indomethacin
Drained dialysate volume mL 11364 9068a
DISCUSSION Creatinine clearance mL/min 0.2360.01 0.1860.02a
Protein clearance mL/min 17.861.4 10.361.3bDuring peritonitis in CAPD patients and in animal Dialysate 6-keto-PGF1a
models, a number of inflammatory mediators are gener- concentration ng/mL 15.961.3 4.863.4b
Dialysate PGE2 concentrationated locally and released into the peritoneal cavity [6–13].
pg/mL 417617 142638bThe current experiments show that dialysate concentra- Dialysate nitrate/nitrite
tions of 6-keto-PGF1a, PGE2 and IL-8, but not nitrate 1 concentration mmol/L 20.763.4 18.962.8
Dialysate IL-8 concentrationnitrite, are elevated during acute peritonitis induced by
pg/mL 13.569.9 21.4611.7the addition of E. coli to the peritoneal cavity of the
Mean 6 SEM values are shown.rabbit. It should be noted that these concentrations are a Lower after IP indomethacin administration (P , 0.05)
b Lower after IP indomethacin administration (P , 0.01)relatively low for inflammatory sites, largely because of
the large volume of dialysate present within the perito-
neal cavity. Although E. coli is not the most common
pathogen causing peritonitis in CAPD patients [1], the is not a feature of E. coli-induced peritonitis in the rabbit,
magnitude of the increase in dialysate concentrations unlike that observed during peritonitis induced by lipo-
of 6-keto-PGF1a, PGE2, and IL-8 is comparable to that polysaccharide or zymosan in the rat [11, 12].
observed during infection of the peritoneal cavity with Prostanoids (mainly PGI2 and PGE2) are generated
other organisms in CAPD patients [8, 9, 16, 17]. While by the oxidation of arachidonic acid by COX and are
increased dialysate concentrations of nitrate 1 nitrite multifunctional mediators of inflammation. The vaso-
have been reported in one study of peritonitis in CAPD active properties of prostaglandins have been recognized
patients [18], an enhanced local production of nitric ox- for many years [20, 21], and they exert their vasodilating
ide was not observed by others [19]. The observations activities by binding to specific cell surface receptors.
from the current study suggest that E. coli-induced peri- This leads to activation of adenylate cyclase and subse-
tonitis in the rabbit elicits some of the same inflammatory quently to elevated intracellular cyclic adenosine mono-
mediators as during peritonitis in CAPD patients. Fur- phosphate levels, which may in turn activate specific pro-
tein kinases. Prostaglandins, by themselves, do not alterthermore, these data show that production of nitric oxide
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Fig. 7. Dialysate to plasma concentration ratios (D/P) for creatinine
as a function of dwell time during both series 1 (j and d) and series 2
(h and s) experiments. No differences in D/P creatinine values were
observed among the study groups. Error bars denote 6 SEM.
tein [8–10]. Despite these statistical correlations, at-
tempts to prove a causal relationship between prostanoid
production and increased peritoneal permeability have
not been convincing. Steinhauer and Schollmeyer ob-
served lower rates of protein loss and lower dialysate
concentrations of PGE2 and 6-keto-PGF1a after intra-
peritoneal administration of indomethacin in four CAPD
patients who were initially resistant to antibiotic treat-
ment [8]; however, the results from these four patients
Fig. 6. Dialysate 6-keto-PGF1a (A) and PGE2 (B) concentrations as a were not compared with those in the control group dur-
function of dwell time during series 2 experiments. Results are shown ing the same phase of peritonitis. More recently, Zemel
after intraperitoneal addition of E. coli without intraperitoneal adminis-
et al also observed lower rates of protein loss (but nottration of indomethacin (j, N 5 4) and after intraperitoneal addition
of both E. coli and indomethacin (s, N 5 4). Error bars denote 6 statistically different from control values) and lower dial-
SEM, and *P , 0.05 and **P , 0.01 denote significant decreases in ysate concentrations of 6-keto-PGF1a, PGE2, and throm-dialysate concentrations at the indicated sampling times after intraperi-
boxane B2 after intraperitoneal administration of indo-toneal administration of indomethacin compared with control values,
respectively. methacin in 11 episodes of peritonitis in nine CAPD
patients than in an untreated (by indomethacin) histori-
cal control group [27]. Comparison between the experi-
mental and control groups might not have been valid in
vascular permeability to macromolecules; rather, they this study because the infections in the experimental
can act synergistically with other inflammatory mediators group were more severe than in the control group, as
to enhance vascular permeability [22, 23]. Indomethacin reflected by substantially higher dialysate leukocyte counts
blocks the conversion of arachidonic acid to biologically (6267 3 106/L vs. 860 3 106/L, respectively).
active prostanoids by inhibiting the activity of both iso- The current study demonstrates that intraperitoneal
forms of COX. It should be noted that the immunomodu- (IP) administration of indomethacin decreased the con-
latory properties of indomethacin are not entirely the centrations of 6-keto-PGF1a and PGE2 in the dialysate
result of its inhibition of the COX system and prostanoid and decreased peritoneal permeability to protein. These
production [24]; thus, the findings of the current study observations strongly suggest that enhanced prostanoid
may be due to other actions of indomethacin, such as production is directly involved in increasing peritoneal
alteration of second-messenger pathways [25] and cyto- permeability to protein during acute peritonitis. Our re-
kine production [26]. sults contrast with those previously reported by Forrest,
Previous work in CAPD patients and in animal models Jose, and Williams, who evaluated the effect of prostan-
has shown that peritoneal inflammation is accompanied oid generation on peritoneal permeability to protein dur-
by an enhanced appearance of prostanoids in the perito- ing zymosan-induced peritonitis in the rabbit [10]. These
investigators observed a nonsignificant increase in dialy-neal cavity and increased peritoneal permeability to pro-
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erans Affairs (USA) and the Dialysis Research Foundation (Ogden,sate concentrations of PGE2 during peritonitis and re- UT, USA). This work was presented in part at the 31st and 32nd
ported that intravenous (IV) administration of indo- Annual Meetings of the American Society of Nephrology that were
held October 25–28, 1998, in Philadelphia, PA, USA, and Novembermethacin (1.8 mg/kg) only reduced albumin loss by 29%.
4–7, 1999, in Miami Beach, FL, USA, and has been published in abstractThe contrasting results between the current study and
form (abstracts; Peng et al, J Am Soc Nephrol 9:287A, 1998, and Peng
those of Forrest, Jose, and Williams may be due to differ- et al, J Am Soc Nephrol 10:227A–228A, 1999). The technical assistance
of Ms. Janice F. Gilson is gratefully acknowledged.ences in the nature of the inflammatory stimulus (E. coli
vs. zymosan) or in the dose and route of administration
Reprint requests to John K. Leypoldt, Ph.D., 85 North Medical Drive
(IP vs. IV) of indomethacin. The latter may be particu- (Front), University of Utah, Salt Lake City, Utah 84112-5350, USA.
E-mail: Ken.Leypoldt@hsc.utah.edularly relevant in this case since Rampart and Williams
have shown that prostaglandins may have either anti-
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